Abbott Laboratories Stock Price. Everything You Need To Know About The Abbott Laboratories Stock! Abbott Laboratories Stock Price. Everything You Need To Know About The Abbott Laboratories Stock!


Understanding Abbott Laboratories Stock Price: A Comprehensive Overview

Are you curious about the Abbott Laboratories stock price and eager to delve into the intricacies of investing in this renowned healthcare company? Abbott Laboratories, headquartered in Abbott Park, Illinois, boasts a workforce of 113,000 employees and is a leading player in the healthcare products industry. Its diverse portfolio encompasses pharmaceuticals, diagnostics, nutritional products, and medical devices, serving markets worldwide. Operating through segments like Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, Abbott Laboratories offers a broad spectrum of innovative solutions to meet diverse healthcare needs.

Investing in Abbott Laboratories Stock: Opportunities for Southeast Asian Investors

For retail investors from Malaysia, Thailand, Indonesia, or Vietnam eyeing opportunities in Abbott Laboratories, Zorion stands as your go-to investment platform. Abbott Laboratories, a prominent US healthcare company, presents promising prospects for portfolio diversification and wealth accumulation. With Zorion’s investment insights and tailored recommendations, investors can navigate the complexities of the stock market with confidence. Our platform equips you with exclusive resources and educational materials, empowering you to make well-informed investment decisions. Embark on your investment journey with Zorion and unlock the potential of Abbott Laboratories today!



Abbott Laboratories Stock Price. Everything You Need To Know About The Abbott Laboratories Stock! performance

  • Employees

    113000
  • Company HQ

    ABBOTT PARK
  • Website

    https://www.abbott.com/
  • ABT Asset Type

    Common Stock
  • ABT Market Capitalization

    202.4B
  • Earnings Per Share 3.25
  • Dividends Per Share 2.08
  • Dividend Date 2024-05-15
  • Quarterly Earnings Growth 0.55

How to Purchase Abbott Laboratories Stock: A Step-by-Step Guide

If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam aiming to invest in Abbott Laboratories, Zorion simplifies the process for you. As a trusted investment platform, Zorion facilitates access to real US stocks, including Abbott Laboratories. Follow these straightforward steps to buy Abbott Laboratories stock: First, create an account on the Zorion platform. Once registered, explore our wealth of resources and educational materials to enhance your investment knowledge. Then, navigate to the stock trading section, search for Abbott Laboratories, and gain instant access to the latest market data, performance charts, and in-depth analysis. At Zorion, we prioritize your financial growth and provide reliable insights and recommendations to support your investment journey.

Analyzing Abbott Laboratories’ Performance: Insights into Financial Strength

Delving into Abbott Laboratories’ analytics and performance sheds light on its financial standing and market dynamics. With robust metrics like EBITDA and PE ratios, Abbott Laboratories demonstrates its potential for earnings and shareholder value. Despite moderate volatility, Abbott Laboratories exhibits stability and strong market performance, reflecting its resilience and market presence. Furthermore, analyzing revenue, profitability, and growth prospects unveils Abbott Laboratories’ financial strength and long-term viability in the healthcare sector. With analysts setting a target price for Abbott Laboratories stock, investors can assess its growth potential and make informed investment decisions.

In conclusion, Abbott Laboratories presents an attractive investment opportunity for retail investors seeking to diversify their portfolios and capitalize on the healthcare industry’s growth. With Zorion’s support and insights, investors from Southeast Asia can embark on their investment journey confidently, leveraging the potential of Abbott Laboratories to achieve their financial goals.

Abbott Laboratories Analytics and Performance


ABT: A Company in the LIFE SCIENCES Sector and PHARMACEUTICAL PREPARATIONS Industry

Discover Abbott Laboratories (ABT), a prominent player in the LIFE SCIENCES sector, specifically within the PHARMACEUTICAL PREPARATIONS industry. As a Common Stock, ABT has a strong presence not only in the United States but also in various countries around the world, including its home base USA.

ABT Financial Performance: Key Ratios and Market Indicators

As of the latest quarter ending 2023-12-31, ABT boasts an EBITDA of 10463000000 and a trailing price-to-earnings ratio (PE ratio) of 35.89. The forward PE ratio stands at 24.27, which indicates stocks potential in earnings. ABT's price-to-sales ratio (TTM) is 5.05, and the price-to-book ratio is 5.19. The company's enterprise value-to-revenue and enterprise value-to-EBITDA ratios are 5.06 and 22.86, respectively.

ABT Stock Stability: Analyzing Marketing Volatility and Trends

ABT stock performance showcases a beta of 0.745, highlighting moderate volatility. The 52-week high and low prices are 117.19 and 89.24, respectively, with a 50-day moving average of 111.04 and a 200-day moving average of 104.98. With 1735180000 shares outstanding, ABT demonstrates strong performance in the market.

ABT Dividends: Current Yields and Shareholder Value

In terms of dividends, Abbott Laboratories has a dividend per share of 2.08 and a dividend yield of 0.0189. The company's most recent dividend date was 2024-05-15, and the ex-dividend date was 2024-04-12. ABT's financials reveal a book value of 22.26 and earnings per share (EPS) of 3.25, with a diluted EPS (TTM) of 3.25.

ABT Revenue and Profitability: Unveiling the Company's Financial Strength

ABT revenue per share (TTM) is 23.05, and its total revenue (TTM) amounts to 40108999000. The company's gross profit (TTM) is 24579000000. ABT's profit margin stands at 0.143, while the operating margin (TTM) is 0.201. The return on assets (TTM) and return on equity (TTM) are 0.0611 and 0.151, respectively.

ABT Growth Prospects: Earnings Growth and Analyst Expectations

ABT has experienced quarterly earnings growth (YOY) of 0.55, but its quarterly revenue growth (YOY) remains stagnant at 0.015. Analysts have set a target price of 125.37 for Abbott Laboratories stock.

Want To Buy Abbott Laboratories Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: